AmerisourceBergen Corporation announced that its wholly owned subsidiary, AmerisourceBergen Canada Corporation, has completed the purchase of all of the stock of Rep-Pharm Inc. for approximately US$48 million. The company expects Rep-Pharm will not be material to earnings.

Headquartered in Oakville, Ontario, Rep-Pharm generated annual revenue of more than US$600 million. Rep-Pharm distributes pharmaceuticals primarily to retail community pharmacies in the provinces of Ontario, Quebec and Alberta.

AmerisourceBergen is one of the world's largest pharmaceutical services companies serving the United States, Canada and selected global markets. Servicing both pharmaceutical manufacturers and healthcare providers in the pharmaceutical supply channel, the company provides drug distribution and related services designed to reduce costs and improve patient outcomes.